Magdalena Żalińska

Factors affecting long-term efficacy of T regulatory cell-based therapy in type 1 diabetes

Natalia Marek-Trzonkowska, Małgorzata Myśliwiec, Dorota Iwaszkiewicz‐Grześ et al. · Journal of Translational Medicine · 2016 · 99 citations · Full text

Combined therapy with <scp>CD4</scp> ⁺ <scp>CD25highCD127</scp> ⁻ T regulatory cells and <scp>anti‐CD20</scp> antibody in recent‐onset type 1 diabetes is superior to monotherapy: Randomized phase I/ <scp>II</scp> trial

Maciej Zieliński, Magdalena Żalińska, Dorota Iwaszkiewicz‐Grześ et al. · Diabetes Obesity and Metabolism · 2022 · 47 citations

Proinsulin-specific T regulatory cells may control immune responses in type 1 diabetes: implications for adoptive therapy

Mateusz Gliwiński, Dorota Iwaszkiewicz‐Grześ, Anna Wołoszyn‐Durkiewicz et al. · BMJ Open Diabetes Research & Care · 2020 · 16 citations · Full text

PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration

Maciej Zieliński, Justyna Sakowska, Dorota Iwaszkiewicz‐Grześ et al. · International Immunopharmacology · 2024 · 11 citations